Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer.

MLA

Viganò, Lucia, et al. “Modulation of the Estrogen/ErbB2 Receptors Cross-Talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-Positive Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 28, no. 10, May 2022, pp. 2167–79. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-21-3185.

APA

Viganò, L., Locatelli, A., Ulisse, A., Galbardi, B., Dugo, M., Tosi, D., Tacchetti, C., Daniele, T., Győrffy, B., Sica, L., Macchini, M., Zambetti, M., Zambelli, S., Bianchini, G., & Gianni, L. (2022). Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 28(10), 2167–2179. https://doi.org/10.1158/1078-0432.CCR-21-3185

Chicago

Viganò, Lucia, Alberta Locatelli, Adele Ulisse, Barbara Galbardi, Matteo Dugo, Diego Tosi, Carlo Tacchetti, et al. 2022. “Modulation of the Estrogen/ErbB2 Receptors Cross-Talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-Positive Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 28 (10): 2167–79. doi:10.1158/1078-0432.CCR-21-3185.